Article detail · 2021 · article
Factors associated with fingolimod rebound: A single center real-life experience
ISSN2211-0348
YÖKSİS
OpenAlex
Year2021
Citations19OpenAlex
Citations18Semantic Scholar · 1 influential
Percentile%87.7
FWCI2.151.00 = world average
Scopus (SJR)Q1
WoS (JCR)Q2
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueMultiple Sclerosis and Related Disorders
- Catalog match (ISSN)Multiple Sclerosis and Related Disorders
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
19citationsOpenAlex · cited_by_count (cache / database)
4 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2023 Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatmentCitations 9 · OpenAlex
- 2023 Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatmentCitations 9 · OpenAlex
- 2023 Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatmentCitations 8 · OpenAlex
- 2023 Comparative effectiveness in multiple sclerosis: A methodological comparison.Citations 8 · OpenAlex